| UTHEALTH HOME ABOUT SBMI A-Z WEBMAIL INSIDE THE UNIVERSITY |
|
|||||||
|
Fusion Protein:COL3A1-COL1A1 |
Fusion Protein Summary |
 Fusion gene summary |
| Fusion partner gene information | Fusion gene name: COL3A1-COL1A1 | FusionPDB ID: 18293 | FusionGDB2.0 ID: 18293 | Hgene | Tgene | Gene symbol | COL3A1 | COL1A1 | Gene ID | 1281 | 1277 |
| Gene name | collagen type III alpha 1 chain | collagen type I alpha 1 chain | |
| Synonyms | EDS4A|EDSVASC|PMGEDSV | CAFYD|EDSARTH1|EDSC|OI1|OI2|OI3|OI4 | |
| Cytomap | 2q32.2 | 17q21.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | collagen alpha-1(III) chainEhlers-Danlos syndrome type IV, autosomal dominantalpha-1 type III collagenalpha1 (III) collagencollagen, fetalcollagen, type III, alpha 1 | collagen alpha-1(I) chainalpha-1 type I collagenalpha1(I) procollagencollagen alpha 1 chain type Icollagen alpha-1(I) chain preproproteincollagen of skin, tendon and bone, alpha-1 chaincollagen, type I, alpha 1pro-alpha-1 collagen type 1type I pro | |
| Modification date | 20200313 | 20200322 | |
| UniProtAcc | P02461 | P02452 | |
| Ensembl transtripts involved in fusion gene | ENST ids | ENST00000304636, ENST00000317840, | ENST00000225964, |
| Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0) | * DoF score | 46 X 40 X 15=27600 | 44 X 105 X 13=60060 |
| # samples | 56 | 80 | |
| ** MAII score | log2(56/27600*10)=-5.62309762960793 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(80/60060*10)=-6.23026066466979 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context (manual curation of fusion genes in FusionPDB) | PubMed: COL3A1 [Title/Abstract] AND COL1A1 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0) | COL1A1(48269148)-COL3A1(189864010), # samples:1 COL3A1(189863444)-COL1A1(48268851), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | COL1A1-COL3A1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. COL1A1-COL3A1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. COL3A1-COL1A1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. COL3A1-COL1A1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF. COL3A1-COL1A1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. COL3A1-COL1A1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | COL3A1 | GO:0007160 | cell-matrix adhesion | 16912226 |
| Hgene | COL3A1 | GO:0007179 | transforming growth factor beta receptor signaling pathway | 16360482 |
| Hgene | COL3A1 | GO:0009314 | response to radiation | 14736764 |
| Hgene | COL3A1 | GO:0018149 | peptide cross-linking | 16754721 |
| Hgene | COL3A1 | GO:0034097 | response to cytokine | 9076960|16360482 |
| Hgene | COL3A1 | GO:0042060 | wound healing | 1466622 |
| Tgene | COL1A1 | GO:0010718 | positive regulation of epithelial to mesenchymal transition | 20018240 |
| Tgene | COL1A1 | GO:0030335 | positive regulation of cell migration | 20018240 |
| Tgene | COL1A1 | GO:0034504 | protein localization to nucleus | 20018240 |
| Tgene | COL1A1 | GO:0045893 | positive regulation of transcription, DNA-templated | 20018240 |
| Tgene | COL1A1 | GO:0090263 | positive regulation of canonical Wnt signaling pathway | 20018240 |
| Fusion gene breakpoints across COL3A1 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across COL1A1 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
Top |
Fusion Gene Sample Information |
| Fusion gene information from FusionGDB2.0. |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | Non-Cancer | 235N | COL3A1 | chr2 | 189863444 | + | COL1A1 | chr17 | 48268851 | - |
Top |
Fusion ORF Analysis |
| Fusion information from ORFfinder translation from full-length transcript sequence from FusionPDB. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000304636 | COL3A1 | chr2 | 189863444 | + | ENST00000225964 | COL1A1 | chr17 | 48268851 | - | 6673 | 2192 | 170 | 4459 | 1429 |
| ENST00000317840 | COL3A1 | chr2 | 189863444 | + | ENST00000225964 | COL1A1 | chr17 | 48268851 | - | 6620 | 2139 | 117 | 4406 | 1429 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000304636 | ENST00000225964 | COL3A1 | chr2 | 189863444 | + | COL1A1 | chr17 | 48268851 | - | 0.001841498 | 0.9981585 |
| ENST00000317840 | ENST00000225964 | COL3A1 | chr2 | 189863444 | + | COL1A1 | chr17 | 48268851 | - | 0.001736051 | 0.998264 |
Top |
Fusion Amino Acid Sequences |
| For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP >18293_18293_1_COL3A1-COL1A1_COL3A1_chr2_189863444_ENST00000304636_COL1A1_chr17_48268851_ENST00000225964_length(amino acids)=1429AA_BP=596 MMSFVQKGSWLLLALLHPTIILAQQEAVEGGCSHLGQSYADRDVWKPEPCQICVCDSGSVLCDDIICDDQELDCPNPEIPFGECCAVCPQ PPTAPTRPPNGQGPQGPKGDPGPPGIPGRNGDPGIPGQPGSPGSPGPPGICESCPTGPQNYSPQYDSYDVKSGVAVGGLAGYPGPAGPPG PPGPPGTSGHPGSPGSPGYQGPPGEPGQAGPSGPPGPPGAIGPSGPAGKDGESGRPGRPGERGLPGPPGIKGPAGIPGFPGMKGHRGFDG RNGEKGETGAPGLKGENGLPGENGAPGPMGPRGAPGERGRPGLPGAAGARGNDGARGSDGQPGPPGPPGTAGFPGSPGAKGEVGPAGSPG SNGAPGQRGEPGPQGHAGAQGPPGPPGINGSPGGKGEMGPAGIPGAPGLMGARGPPGPAGANGAPGLRGGAGEPGKNGAKGEPGPRGERG EAGIPGVPGAKGEDGKDGSPGEPGANGLPGAAGERGAPGFRGPAGPNGIPGEKGPAGERGAPGPAGPRGAAGEPGRDGVPGGPGMRGMPG SPGGPGSDGKPGPPGSQGESGRPGPPGPSGPRGQPGVMGFPGPKGNDGAPGKNGERGGPGGPGPQGPPGKNGETGPQGPPGPTGPGGDKG DTGPPGPQGLQGLPGTGGPPGENGKPGEPGPKGDAGAPGAPGGKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADG SPGKDGVRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAG PAGPPGPIGNVGAPGAKGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKG SPGADGPAGAPGTPGPQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPG RDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAGKSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSG LQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPP QEKAHDGGRYYRADDANVVRDRDLEVDTTLKSLSQQIENIRSPEGSRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFCNMET GETCVYPTQPSVAQKNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAIQLTFLRLMSTEASQNITYHCKNSVAYMDQQTGNLK -------------------------------------------------------------- >18293_18293_2_COL3A1-COL1A1_COL3A1_chr2_189863444_ENST00000317840_COL1A1_chr17_48268851_ENST00000225964_length(amino acids)=1429AA_BP=596 MMSFVQKGSWLLLALLHPTIILAQQEAVEGGCSHLGQSYADRDVWKPEPCQICVCDSGSVLCDDIICDDQELDCPNPEIPFGECCAVCPQ PPTAPTRPPNGQGPQGPKGDPGPPGIPGRNGDPGIPGQPGSPGSPGPPGICESCPTGPQNYSPQYDSYDVKSGVAVGGLAGYPGPAGPPG PPGPPGTSGHPGSPGSPGYQGPPGEPGQAGPSGPPGPPGAIGPSGPAGKDGESGRPGRPGERGLPGPPGIKGPAGIPGFPGMKGHRGFDG RNGEKGETGAPGLKGENGLPGENGAPGPMGPRGAPGERGRPGLPGAAGARGNDGARGSDGQPGPPGPPGTAGFPGSPGAKGEVGPAGSPG SNGAPGQRGEPGPQGHAGAQGPPGPPGINGSPGGKGEMGPAGIPGAPGLMGARGPPGPAGANGAPGLRGGAGEPGKNGAKGEPGPRGERG EAGIPGVPGAKGEDGKDGSPGEPGANGLPGAAGERGAPGFRGPAGPNGIPGEKGPAGERGAPGPAGPRGAAGEPGRDGVPGGPGMRGMPG SPGGPGSDGKPGPPGSQGESGRPGPPGPSGPRGQPGVMGFPGPKGNDGAPGKNGERGGPGGPGPQGPPGKNGETGPQGPPGPTGPGGDKG DTGPPGPQGLQGLPGTGGPPGENGKPGEPGPKGDAGAPGAPGGKGDAGAPGAPGSQGAPGLQGMPGERGAAGLPGPKGDRGDAGPKGADG SPGKDGVRGLTGPIGPPGPAGAPGDKGESGPSGPAGPTGARGAPGDRGEPGPPGPAGFAGPPGADGQPGAKGEPGDAGAKGDAGPPGPAG PAGPPGPIGNVGAPGAKGARGSAGPPGATGFPGAAGRVGPPGPSGNAGPPGPPGPAGKEGGKGPRGETGPAGRPGEVGPPGPPGPAGEKG SPGADGPAGAPGTPGPQGIAGQRGVVGLPGQRGERGFPGLPGPSGEPGKQGPSGASGERGPPGPMGPPGLAGPPGESGREGAPGAEGSPG RDGSPGAKGDRGETGPAGPPGAPGAPGAPGPVGPAGKSGDRGETGPAGPTGPVGPVGARGPAGPQGPRGDKGETGEQGDRGIKGHRGFSG LQGPPGPPGSPGEQGPSGASGPAGPRGPPGSAGAPGKDGLNGLPGPIGPPGPRGRTGDAGPVGPPGPPGPPGPPGPPSAGFDFSFLPQPP QEKAHDGGRYYRADDANVVRDRDLEVDTTLKSLSQQIENIRSPEGSRKNPARTCRDLKMCHSDWKSGEYWIDPNQGCNLDAIKVFCNMET GETCVYPTQPSVAQKNWYISKNPKDKRHVWFGESMTDGFQFEYGGQGSDPADVAIQLTFLRLMSTEASQNITYHCKNSVAYMDQQTGNLK -------------------------------------------------------------- |
Top |
Fusion Protein Functional Features |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr2:48269148/chr17:189864010) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| COL3A1 | COL1A1 |
| FUNCTION: Collagen type III occurs in most soft connective tissues along with type I collagen. Involved in regulation of cortical development. Is the major ligand of ADGRG1 in the developing brain and binding to ADGRG1 inhibits neuronal migration and activates the RhoA pathway by coupling ADGRG1 to GNA13 and possibly GNA12. | FUNCTION: Type I collagen is a member of group I collagen (fibrillar forming collagen). |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - Retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | COL3A1 | chr2:189863444 | chr17:48268851 | ENST00000304636 | + | 29 | 51 | 30_89 | 674.0 | 1467.0 | Domain | VWFC |
| Hgene | COL3A1 | chr2:189863444 | chr17:48268851 | ENST00000304636 | + | 29 | 51 | 149_167 | 674.0 | 1467.0 | Region | Note=Nonhelical region (N-terminal) |
| Tgene | COL1A1 | chr2:189863444 | chr17:48268851 | ENST00000225964 | 30 | 51 | 1229_1464 | 709.0 | 1465.0 | Domain | Fibrillar collagen NC1 | |
| Tgene | COL1A1 | chr2:189863444 | chr17:48268851 | ENST00000225964 | 30 | 51 | 1093_1095 | 709.0 | 1465.0 | Motif | Cell attachment site | |
| Tgene | COL1A1 | chr2:189863444 | chr17:48268851 | ENST00000225964 | 30 | 51 | 745_747 | 709.0 | 1465.0 | Motif | Cell attachment site | |
| Tgene | COL1A1 | chr2:189863444 | chr17:48268851 | ENST00000225964 | 30 | 51 | 1193_1218 | 709.0 | 1465.0 | Region | Note=Nonhelical region (C-terminal) |
| - Not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | COL3A1 | chr2:189863444 | chr17:48268851 | ENST00000304636 | + | 29 | 51 | 1232_1466 | 674.0 | 1467.0 | Domain | Fibrillar collagen NC1 |
| Hgene | COL3A1 | chr2:189863444 | chr17:48268851 | ENST00000304636 | + | 29 | 51 | 1197_1205 | 674.0 | 1467.0 | Region | Note=Nonhelical region (C-terminal) |
| Hgene | COL3A1 | chr2:189863444 | chr17:48268851 | ENST00000304636 | + | 29 | 51 | 168_1196 | 674.0 | 1467.0 | Region | Note=Triple-helical region |
| Tgene | COL1A1 | chr2:189863444 | chr17:48268851 | ENST00000225964 | 30 | 51 | 38_96 | 709.0 | 1465.0 | Domain | VWFC | |
| Tgene | COL1A1 | chr2:189863444 | chr17:48268851 | ENST00000225964 | 30 | 51 | 162_178 | 709.0 | 1465.0 | Region | Note=Nonhelical region (N-terminal) | |
| Tgene | COL1A1 | chr2:189863444 | chr17:48268851 | ENST00000225964 | 30 | 51 | 179_1192 | 709.0 | 1465.0 | Region | Note=Triple-helical region |
Top |
Fusion Protein-Protein Interaction |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type from validated records (BIOGRID-3.4.160) |
| Gene | PPI interactors |
| COL1A1 | IGFBP3, TXN, ITGA2, ITGB1, NID1, Nid1, NID2, SPARC, PRELP, PKD1, VWF, THBS1, MMP2, COL7A1, MATN2, MAG, ELAVL1, ATP13A2, C12orf57, RNH1, BARD1, BRCA1, UBC, CAPN1, COL1A1, COL1A2, PDGFA, PDGFB, GIPC2, UBXN11, DNM3, CD200R1, TMTC4, ERAL1, CAMKMT, TMEM180, OTUB1, EGFR, COLGALT2, P4HA2, PLOD1, LIN9, TIMM44, RASGEF1B, TLE3, YAF2, LPAR1, CYLD, MCPH1, HEXIM1, PPP1CC, KEAP1, PINK1, CDC42, NMRAL1, PAX3, NTPCR, FOXO1, IGLC1, DDX58, YIPF1, LAIR2, LAT, KIAA1191, SLC25A40, CTNND1, FOXD3, CHMP3, ZNF645, CD247, RANBP6, TRIM41, TNFRSF10D, KIR3DS1, SMDT1, PPIA, PEG10, TMEM44, RNF144A, VCP, TESPA1, ABHD14A, TADA1, ST3GAL3, KLF15, BGN, TGM2, COL18A1, NLRP7, |
| Protein-protein interactors based on sequence similarity (STRING) |
| Gene | STRING network |
| COL3A1 | |
| COL1A1 |  |
| - Retained interactions in fusion protein (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost interactions due to fusion (protein functional feature from UniProt). |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs to COL3A1-COL1A1 |
| Drugs used for this fusion-positive patient. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Drug | Source | PMID |
Top |
Related Diseases to COL3A1-COL1A1 |
| Diseases that have this fusion gene. (Manual curation of PubMed, 04-30-2022 + MyCancerGenome) |
| Hgene | Tgene | Disease | Source | PMID |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Tgene | COL1A1 | C0268358 | Osteogenesis imperfecta, dominant perinatal lethal | 38 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | COL1A1 | C0268362 | Osteogenesis imperfecta type III (disorder) | 17 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | COL1A1 | C0023931 | Lobstein Disease | 15 | CTD_human;GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | COL1A1 | C0268363 | Osteogenesis imperfecta type IV (disorder) | 12 | GENOMICS_ENGLAND;ORPHANET;UNIPROT |
| Tgene | COL1A1 | C0023890 | Liver Cirrhosis | 4 | CTD_human |
| Tgene | COL1A1 | C0239946 | Fibrosis, Liver | 4 | CTD_human |
| Tgene | COL1A1 | C4551623 | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1 | 4 | CTD_human;GENOMICS_ENGLAND |
| Tgene | COL1A1 | C4552122 | EHLERS-DANLOS SYNDROME, CLASSIC TYPE, 1 | 4 | GENOMICS_ENGLAND;UNIPROT |
| Tgene | COL1A1 | C0020497 | Cortical Congenital Hyperostosis | 3 | CTD_human;GENOMICS_ENGLAND;UNIPROT |
| Tgene | COL1A1 | C0023893 | Liver Cirrhosis, Experimental | 3 | CTD_human |
| Tgene | COL1A1 | C0268345 | EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE | 2 | ORPHANET |
| Tgene | COL1A1 | C0000786 | Spontaneous abortion | 1 | CTD_human |
| Tgene | COL1A1 | C0000822 | Abortion, Tubal | 1 | CTD_human |
| Tgene | COL1A1 | C0002949 | Aneurysm, Dissecting | 1 | CTD_human |
| Tgene | COL1A1 | C0003504 | Aortic Valve Insufficiency | 1 | CTD_human |
| Tgene | COL1A1 | C0004364 | Autoimmune Diseases | 1 | CTD_human |
| Tgene | COL1A1 | C0005398 | Cholestasis, Extrahepatic | 1 | CTD_human |
| Tgene | COL1A1 | C0005779 | Blood Coagulation Disorders | 1 | GENOMICS_ENGLAND |
| Tgene | COL1A1 | C0006663 | Calcinosis | 1 | CTD_human |
| Tgene | COL1A1 | C0008311 | Cholangitis | 1 | CTD_human |
| Tgene | COL1A1 | C0013720 | Ehlers-Danlos Syndrome | 1 | GENOMICS_ENGLAND |
| Tgene | COL1A1 | C0016059 | Fibrosis | 1 | CTD_human |
| Tgene | COL1A1 | C0018824 | Heart valve disease | 1 | CTD_human |
| Tgene | COL1A1 | C0020538 | Hypertensive disease | 1 | CTD_human |
| Tgene | COL1A1 | C0022548 | Keloid | 1 | CTD_human |
| Tgene | COL1A1 | C0027719 | Nephrosclerosis | 1 | CTD_human |
| Tgene | COL1A1 | C0027726 | Nephrotic Syndrome | 1 | CTD_human |
| Tgene | COL1A1 | C0029172 | Oral Submucous Fibrosis | 1 | CTD_human |
| Tgene | COL1A1 | C0029434 | Osteogenesis Imperfecta | 1 | CTD_human;GENOMICS_ENGLAND |
| Tgene | COL1A1 | C0149721 | Left Ventricular Hypertrophy | 1 | CTD_human |
| Tgene | COL1A1 | C0220679 | Ehlers-Danlos Syndrome, Autosomal Dominant, Type Unspecified | 1 | ORPHANET |
| Tgene | COL1A1 | C0263628 | Tumoral calcinosis | 1 | CTD_human |
| Tgene | COL1A1 | C0340643 | Dissection of aorta | 1 | CTD_human |
| Tgene | COL1A1 | C0521174 | Microcalcification | 1 | CTD_human |
| Tgene | COL1A1 | C1458140 | Bleeding tendency | 1 | GENOMICS_ENGLAND |
| Tgene | COL1A1 | C1619692 | Nephrogenic Fibrosing Dermopathy | 1 | CTD_human |
| Tgene | COL1A1 | C1623038 | Cirrhosis | 1 | CTD_human |
| Tgene | COL1A1 | C1846545 | Autoimmune Lymphoproliferative Syndrome Type 2B | 1 | GENOMICS_ENGLAND |
| Tgene | COL1A1 | C3830362 | Early Pregnancy Loss | 1 | CTD_human |
| Tgene | COL1A1 | C4277533 | Dissection, Blood Vessel | 1 | CTD_human |
| Tgene | COL1A1 | C4552766 | Miscarriage | 1 | CTD_human |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies